Furthermore, MDA-MB-231 mammary tumour cells seeded into the CDM derived from fibroblasts in which BNC2 had been knocked down exhibited a trend towards reduced motility relative to those seeded into CDM derived from fibroblasts that had been transfected with control non-targeting siRNA (Fig 6E). This evidence concerns the gene BNC2 and breast cancer.